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Introduction {#sec005}
============

Malnutrition as defined by the World Health Organisation (WHO) refers to a deficiency of nutrition\[[@pone.0156008.ref001]\] whilst cachexia is a complex metabolic syndrome associated with underlying cancer and characterized by loss of muscle with or without fat mass\[[@pone.0156008.ref002],[@pone.0156008.ref003]\]. It is widely acknowledged that both malnutrition and cachexia are under diagnosed and under treated in patients with cancer\[[@pone.0156008.ref004]--[@pone.0156008.ref006]\]. Their prevalence varies largely depending on evaluation criteria and has been estimated to range up to as high as 85% in all cancer patients\[[@pone.0156008.ref003],[@pone.0156008.ref007]--[@pone.0156008.ref010]\] Malnutrition and cachexia have been shown to be a predictors of risk of toxicity to chemotherapy, impaired quality of life and mortality\[[@pone.0156008.ref003],[@pone.0156008.ref011]--[@pone.0156008.ref016]\]. In addition, the experience of weight loss by patients with advanced cancer is distressing for it is viewed as symbolizing proximity of death, loss of control and weakness both emotionally and physically\[[@pone.0156008.ref017]\].

The elderly patient is particularly prone to inadequate nutritional intake because of factors such as concomitant chronic diseases, polypharmacy, decreased mobility, social changes as well as age related physiological changes\[[@pone.0156008.ref018]\].

It is a general consensus that malnutrition or cachexia should ideally be recognised in the earlier phase of anti-cancer therapy which offers a window of opportunity for intervention\[[@pone.0156008.ref003]\]. Early identification of elderly patients at nutritional risk would allow for a quick and timely referral to an appropriately trained professional for a comprehensive nutritional assessment and targeted nutritional intervention which is more likely to be effective before pronounce metabolic deficiencies render them resistant\[[@pone.0156008.ref003]\].

Evidence based guidelines for the management of elderly patients with cancer recommends a comprehensive geriatric assessment (CGA) to detect unrecognised problems and improve function as well as outcomes\[[@pone.0156008.ref019]\]. Nutritional assessment is an important component of the CGA. A complete nutritional assessment is complex and usually performed by an appropriately trained professional such as a dietician. An in depth assessment would involve clinical, physical, psychological considerations in addition to anthropometry, biochemical and haematological assessments\[[@pone.0156008.ref008]\]. This would not be practical for day to day use given the time and manpower constraint of a busy oncology practice.

Nutritional screening on the other hand is quick, easy and provides an indication of a patient's nutritional risk. Several tools have been designed and available for use in specific patient groups however the absence of a universally agreed criteria in identifying malnutrition has resulted in a lack of consensus among experts as to the "best" or "correct" way of screening for nutritional status \[[@pone.0156008.ref020]--[@pone.0156008.ref023]\]

One such screening tool is the Nutrition Screening Initiative (NSI) Checklist\[[@pone.0156008.ref020]\]. The NSI is an American national effort to increase public and health professional awareness of the importance of nutritional problems among older persons\[[@pone.0156008.ref020]\]. It consists of a self-administered awareness checklist describing characteristics associated with poor nutritional status and was designed to predict adequacy of nutrient intake and overall perceived health\[[@pone.0156008.ref020]\]. The NSI checklist identifies older persons at nutritional risk due to inadequate nutrient intake as defined by an intake of less than 75% of the recommended daily allowance (RDA) and is used throughout the United States in the assessment of nutrition risk\[[@pone.0156008.ref020]\].

To date there is a scarcity of studies evaluating malnutrition or nutritional risk in elderly Asian patients. Most of the validated screening tools consist of items such as current weight or body mass index (BMI), decreased dietary intake and unintentional weight loss\[[@pone.0156008.ref023]\]. None of the available and validated screening tools are based on clinical factors in elderly patients in the setting of a diagnosis of cancer in Asia. We aim to identify CGA based clinical characteristics in elderly Asian cancer patients which are associated with moderate to high nutritional risk as determined by the NSI checklist\[[@pone.0156008.ref020]\]. These clinical risk factors, which are routinely evaluated in the clinic can form the basis for a simplified screening tool for nutritional risk in the elderly Asian cancer patients.

Patients and Methods {#sec006}
====================

Study Design and Patients {#sec007}
-------------------------

This is a retrospective analysis of the CGA data collected from elderly patients attending outpatient oncology clinics at the National Cancer Centre Singapore between May 2007 and November 2010. Patients aged 70 years and older with a diagnosis of cancer at any stage were interviewed by a research nurse prior to their first visit with an oncologist. All patients provided written informed consent before inclusion into the study. The study was approved by the local institutional review board and conducted according to the principles expressed in the Declaration of Helsinki.

Clinical Data {#sec008}
-------------

The CGA questionnaire used in this study was previously described\[[@pone.0156008.ref024]\] and was developed after a thorough review of the literature and guideline recommendations. The CGA consists of seven distinct domains. Functional status was assessed using Eastern Cooperative Oncology Group (ECOG) performance status\[[@pone.0156008.ref025]\], the index of activities of daily living (ADL)\[[@pone.0156008.ref026]\], instrumental activities of daily living (IADL) of Lawton et al\[[@pone.0156008.ref027]\], the get up and go test\[[@pone.0156008.ref028]\], and the dominant handgrip strength test. Comorbidities were classified according to the Charlson comorbidity index\[[@pone.0156008.ref029]\]. Cognitive status was assessed using the mini-mental state examination (MMSE) \[[@pone.0156008.ref030]\] and clock drawing test\[[@pone.0156008.ref031]\]. Affective status was assessed via the Geriatric Depression Scale (GDS) Short Form 15\[[@pone.0156008.ref032]\]. Polypharmacy was documented in terms of number of medications, appropriateness and interactions. Geriatric syndromes were those as described by Balducci et al\[[@pone.0156008.ref033]\] and nutritional status, was assessed using the body mass index (BMI) and The NSI checklist ([Table 1](#pone.0156008.t001){ref-type="table"})\[[@pone.0156008.ref020]\]. The checklist classified patients into low (0 to 2 points), moderate (3 to 5 points) and high nutritional risk (≥6 points) groups. Clinical parameters such as age, sex, stage, tumour types and selected laboratory tests (e.g. haemoglobin, albumin, renal panel, liver function tests) routinely available to treating clinicians were also collected.

10.1371/journal.pone.0156008.t001

###### The Nutrition Screening Initiative Checklist.

![](pone.0156008.t001){#pone.0156008.t001g}

  Statement                                                                                   Yes
  ------------------------------------------------------------------------------------------- ---------
  I have an illness or condition that made me change the kind and / or amount of food I eat   2
  I eat fewer than 2 meals per day                                                            3
  I eat few fruits or vegetables or milk products                                             2
  I have 3 or more drinks of beer, liquor or wine almost everyday                             2
  I have tooth or mouth problems that make it hard for me to eat                              2
  I don't always have enough money to buy the food I need                                     4
  I eat alone most of the time                                                                1
  I take 3 or more different prescribed or over-the-counter drugs a day                       1
  Without want to, I have lost of gained 10 pounds in the last 6 months                       2
  I am not physically able to shop, cook and / or feed myself                                 2
  Total Score                                                                                 **/21**

Nutritional score: 0--2 low nutritional risk; 3--5 Moderate nutritional risk, 6 or more High nutritional risk

Statistical Analysis {#sec009}
--------------------

Demographic and clinical characteristics between patients with and without moderate to high nutritional risk were compared. Categorical characteristics were compared using the Chi-square test of Fisher's exact test as appropriate. Mann-Whitney U test was used to compare continuous characteristics between 2 groups of patients. Logistic regression models were fitted to estimate the odds ratios to assess the association of various variables with moderate to high nutritional risk. Considering the large number of significant predictors from the univariate analysis and to avoid model over-fitting, multivariate analyses were performed only on variables with p\<0.01 from the univariate analysis. Forward selection, backward elimination and stepwise selection algorithms were applied to identify independent predictors. Goodness of fit between the observed and predicted number of outcomes of the multivariate model were assessed based on the Hosmer-Lemeshow test and its discrimination ability assessed based on the area under the receiver operating characteristics curve (AUC). The AUC was further internally validated based on 200 simulated datasets via bootstrapping to correct for over-fit bias. All p-values were 2 sided and a p-value \<0.05 was considered statistically significant. All analyses were performed using SAS version 9.3 (SAS Institute Inc., Cary, NC) and R 2.15.0 ([http://www.R-project.org](http://www.r-project.org/)).

Results {#sec010}
=======

Patient Characteristics {#sec011}
-----------------------

This analysis included 249 patients with a median age of 77 (range 70--94). Majority of the patients were male (61.4%) and of Chinese race (91.2%). Gastrointestinal (GI) tract cancers were the primary tumor sites in 67.1% of patients followed by lung cancer (11.6%) and genitourinary cancer (4.8%). Most of the patients had late stage cancer (84.7%) and poorer performance status of 2 or greater (66.7%). [Table 2](#pone.0156008.t002){ref-type="table"} lists the patient characteristics.

10.1371/journal.pone.0156008.t002

###### Patient characteristics by nutritional risk.

![](pone.0156008.t002){#pone.0156008.t002g}

  Variable                                        Total (n = 249)   Low nutritional risk(n = 65)   Moderate / High nutritional risk (n = 184)   P                      
  ----------------------------------------------- ----------------- ------------------------------ -------------------------------------------- --------- ----- ------ ----------
  ***Age at CGA assessment*, *years***                                                                                                                                 
  Median (range)                                  77 (70--94)       76 (70--93)                    77 (70--94)                                  0.903                  
  ***Gender***                                                                                                                                                         
  Male                                            153               61.4                           45                                           69.2      108   58.7   0.134
  Female                                          96                38.6                           20                                           30.8      76    41.3   
  ***Race***                                                                                                                                                           
  Chinese                                         227               91.2                           60                                           92.3      167   90.8   0.073
  Malays                                          12                4.8                            2                                            3.1       10    5.4    
  Indians                                         6                 2.4                            0                                            0         6     3.3    
  Others                                          4                 1.6                            3                                            4.6       1     0.5    
  ***Primary tumour site***                                                                                                                                            
  Head and neck                                   6                 2.4                            1                                            1.5       5     2.7    0.003
  GI tract                                        167               67.1                           33                                           50.8      134   72.8   
  Breast                                          5                 2.0                            1                                            1.5       4     2.2    
  Gynaecologic                                    2                 0.8                            2                                            3.1       0     0      
  Lung                                            29                11.6                           15                                           23.1      14    7.6    
  Lymphoma                                        2                 0.8                            0                                            0         2     1.1    
  Genitourinary                                   12                4.8                            4                                            6.2       8     4.3    
  Dual primaries                                  7                 2.8                            1                                            1.5       6     3.3    
  Others                                          19                7.6                            8                                            12.3      11    6.0    
  ***Stage at diagnosis***                                                                                                                                             
  Early (I--II)                                   38                15.3                           19                                           29.2      19    10.4   \<0.001
  Late (III--IV)                                  210               84.7                           46                                           70.8      164   89.6   
  ***ECOG performance status***                                                                                                                                        
  0--1                                            83                33.3                           38                                           58.5      45    24.5   \<0.001
  2--4                                            166               66.7                           27                                           41.5      139   75.5   
  ***Activities of daily living***                                                                                                                                     
  Independent (A--F)                              204               81.9                           62                                           95.4      142   77.2   0.001
  Dependent (G & Others)                          45                18.1                           3                                            4.6       42    22.8   
  ***Instrumental activities of daily living***                                                                                                                        
  \< 7                                            219               88.3                           49                                           76.6      170   92.4   0.001
  ≥ 7                                             29                11.7                           15                                           23.4      14    7.6    
  ***Get up and go test***                                                                                                                                             
  Normal                                          81                32.8                           28                                           43.1      53    29.1   0.011
  Very slightly abnormal                          80                32.4                           25                                           38.5      55    30.2   
  Mildly abnormal                                 35                14.2                           8                                            12.3      27    14.8   
  Moderately abnormal                             19                7.7                            2                                            3.1       17    9.3    
  Severely abnormal                               32                13.0                           2                                            3.1       30    16.5   
  ***Dominant handgrip strength test*, *kg***                                                                                                                          
  Median (range)                                  30 (0--90)        40 (3.3--90)                   26.7 (0--80)                                 \<0.001                
  ***Charlson comorbidity index***                                                                                                                                     
  Low                                             83                33.3                           22                                           33.8      61    33.2   0.845
  Medium                                          116               46.6                           31                                           47.7      85    46.2   
  High                                            37                14.9                           10                                           15.4      27    14.7   
  Very high                                       13                5.2                            2                                            3.1       11    6.0    
  ***Clock drawing test score***                                                                                                                                       
  Normal (≤2)                                     96                41.7                           32                                           51.6      64    38.1   0.065
  Abnormal (\>2)                                  134               58.3                           30                                           48.4      104   61.9   
  ***Mini-mental state examination score***                                                                                                                            
  Normal (≥24)                                    163               67.6                           53                                           82.8      110   62.1   0.003
  Abnormal (\<24)                                 78                32.4                           11                                           17.2      67    37.9   
  ***Geriatric depression scale***                                                                                                                                     
  Normal (≤5)                                     177               71.7                           60                                           93.8      117   63.9   \<0.001
  Depressed (\>5)                                 70                28.3                           4                                            6.3       66    36.1   
  ***Caregiver burden***                                                                                                                                               
  Little or no burden                             188               77.0                           57                                           89.1      131   72.8   0.013
  Mild to moderate burden                         55                22.5                           7                                            10.9      48    26.7   
  Moderate to severe burden                       1                 0.4                            0                                            0         1     0.6    
  ***Polypharmacy (\>4 prescribed drugs)***                                                                                                                            
  No                                              98                39.5                           36                                           56.3      62    33.7   0.002
  Yes                                             150               60.5                           28                                           43.8      122   66.3   
  ***Presence of geriatric syndromes***                                                                                                                                
  No                                              98                39.4                           41                                           63.1      57    31.0   \<0.001
  Yes                                             151               60.6                           24                                           36.9      127   69.0   
  ***BMI***                                                                                                                                                            
  \< 27.5                                         232               93.5                           55                                           85.9      177   96.2   0.007
  ≥ 27.5                                          16                6.5                            9                                            14.1      7     3.8    
  ***Haemoglobin*, *g/dL***                                                                                                                                            
  Normal (≥12)                                    106               43.3                           43                                           68.3      63    34.6   \< 0.001
  Abnormal (\<12)                                 139               56.7                           20                                           31.7      119   65.4   
  ***Creatinine clearance test*, *ml/min***                                                                                                                            
  Normal (≥60)                                    156               68.1                           40                                           71.4      116   67.1   0.541
  Abnormal (\<60)                                 73                31.9                           16                                           28.6      57    32.9   
  ***Albumin*, *g/L***                                                                                                                                                 
  Normal (\>35)                                   53                22.9                           25                                           42.4      28    16.3   \< 0.001
  Abnormal (≤35)                                  178               77.1                           34                                           57.6      144   83.7   
  ***Bilirubin*, *μmol/L***                                                                                                                                            
  Normal (≤24)                                    195               84.8                           49                                           84.5      146   84.9   0.941
  Abnormal (\>24)                                 35                15.2                           9                                            15.5      26    15.1   
  ***ALT*, *U/L***                                                                                                                                                     
  Normal (≤36)                                    186               80.5                           49                                           84.5      137   79.2   0.379
  Abnormal (\>36)                                 45                19.5                           9                                            15.5      36    20.8   
  ***AST*, *U/L***                                                                                                                                                     
  Normal (≤33)                                    145               63.0                           37                                           64.9      108   62.4   0.736
  Abnormal (\>33)                                 85                37.0                           20                                           35.1      65    37.6   

Abbreviations: CGA, comprehensive geriatric assessment; ECOG, Eastern Coorperative Oncology Group; BMI, Body Mass Index; ALT, alanine transaminase; AST, aspartate transaminase

Patient characteristics by nutritional risk {#sec012}
-------------------------------------------

A significant proportion of patients (73.9%) were at moderate to high nutritional risk. Compared with patients with low nutritional risk, there were significantly more patients with moderate to high nutritional risk who had primary tumour in the GI tract (73% vs 51%), ECOG performance status 2--4 (76% vs 42%), advanced stage of disease at diagnosis (90% vs 71%), depression based on geriatric depression scale (36% vs 6%), low MMSE scores (\< 24 points) (38% vs 17%), imposed mild to severe burden to their caregivers (27% vs 11%), had more than 4 prescribed drugs (66% vs 44%) and the presence of geriatric syndromes (69% vs 37%) (all p \< 0.02).

Patients with moderate to high nutritional risk also had significantly lower median BMI values (20.9 vs 23.7), haemoglobin levels (11.1 vs 12.5 g/dL), and albumin levels (29.0 vs 34.0 g/L) (all p \< 0.001).

There were no significant differences in age, gender, comorbidity risk, renal and liver functions between the 2 groups of patients.

Univariate logistic regression analysis {#sec013}
---------------------------------------

Factors that were significantly associated with moderate to high nutritional risk included an advanced stage at diagnosis \[odds ratio (OR) 3.57; 95% confidence interval (CI) 1.74--7.29\], a higher ECOG performance status of 2--4 (OR 4.35; 95% CI 2.39--7.90), being dependent in ADL (OR 6.11; 95% CI 1.83--20.47), a lower score in IADL (OR 1.43; 95% CI 1.23--1.67), a lower score in dominant handgrip strength test (OR 0.95; 95% CI 0.94--0.97), MMSE score \< 24 (OR 2.94; 95% CI 1.43--6.01), GDS score \> 5 (OR 8.46; 95% CI 2.94--24.33), presence of geriatric syndromes (OR 3.81; 95% CI 2.10--6.89), imposing mild to severe burden to caregivers (OR 3.05; 95% CI 1.30--7.13), having more than 4 prescribed drugs (OR 2.53; 95% CI 1.42--4.52), a lower BMI value (OR 1.23; 95% CI 1.14--1.35), lower haemoglobin levels (OR 1.43; 95% CI 1.22--1.69) and lower albumin levels (OR 1.14; 95% CI 1.08--1.20) ([Table 3](#pone.0156008.t003){ref-type="table"}).

10.1371/journal.pone.0156008.t003

###### Univariate logistic regression of moderate to high nutritional risk.
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  Variable                              Categories                                     OR     95% CI        *P*
  ------------------------------------- ---------------------------------------------- ------ ------------- ---------
  Primary tumour site                   GI tract vs Head & neck                        0.81   0.09--7.19    0.044
                                        Breast vs Head & neck                          0.80   0.04--17.20   
                                        Gynaecologic vs Head & neck                    NE     NE            
                                        Lung vs Head & neck                            0.19   0.02--1.80    
                                        Lymphoma vs Head & neck                        NE     NE            
                                        Genitourinary vs Head & neck                   0.40   0.03--4.68    
                                        Dual primaries vs Head & neck                  1.20   0.06--24.47   
                                        Others vs Head & neck                          0.28   0.03--2.83    
  Stage at diagnosis                    Late (III--IV) vs Early (I--II)                3.57   1.74--7.29    0.001
  Metastasis at diagnosis               Yes vs No                                      1.79   1.01--3.17    0.048
  ECOG performance status               2--4 vs 0--1                                   4.35   2.39--7.90    \<0.001
  ADL                                   Dependent (G & Others) vs Independent (A--F)   6.11   1.83--20.47   0.003
  Instrumental ADL                      ≥ 7 vs \< 7                                    0.27   0.12--0.60    0.001
  Get up and go test                    Very slightly abnormal vs Normal               1.16   0.60--2.25    0.027
                                        Mildly abnormal vs Normal                      1.78   0.72--4.44    
                                        Moderately abnormal vs Normal                  4.49   0.97--20.84   
                                        Severely abnormal vs Normal                    7.92   1.76--35.61   
  Dominant handgrip strength test       Per kg increase                                0.95   0.94--0.97    \<0.001
  Clock drawing test score              Abnormal (\>2) vs Normal (≤2)                  1.73   0.96--3.12    0.067
  Mini-mental state examination score   Abnormal (\<24) vs Normal (≥24)                2.94   1.43--6.01    0.003
  Geriatric depression scale            Depressed (\>5) vs Normal (≤5)                 8.46   2.94--24.33   \<0.001
  Caregiver burden                      Mild to severe vs Little or no                 3.05   1.30--7.13    0.010
  Polypharmacy                          Yes vs No                                      2.53   1.42--4.52    0.002
  BMI                                   ≥ 27.5 vs \< 27.5                              0.24   0.09--0.68    0.007
  Haemoglobin, g/dL                     Abnormal (\<12) vs Normal (≥12)                4.06   2.20--7.49    \<0.001
  Albumin, g/L                          Abnormal (≤35) vs Normal (\>35)                3.78   1.96--7.29    \<0.001
  Geriatric syndromes                   Yes vs No                                      3.81   2.10--6.89    \<0.001

Abbreviations: OR, odds ratio; CI, confidence interval; NE, not estimable; ECOG, Eastern Cooperative Oncology Group; ADL, activities of daily living; BMI, body mass index

Multivariate logistic regression analysis {#sec014}
-----------------------------------------

Multivariate logistic regression analysis using forward selection, backward elimination and stepwise selection algorithms identified identical predictors for moderate to high nutritional risk ([Table 4](#pone.0156008.t004){ref-type="table"}). Stage 3--4 at diagnosis (OR 2.54; 95% CI 1.14--5.69; p = 0.023), ECOG performance status of 2--4 (OR 3.04; 95% CI 1.57--5.88; p = 0.001), presence of depression as measured by GDS (OR 5.99; 95% CI 1.99--18.02; p = 0.001) and haemoglobin levels \< 12 g/dl (OR 3.00; 95% CI 1,54--5.84; p = 0.001) were all statistically significant independent factors associated with moderate to high nutritional risk.

10.1371/journal.pone.0156008.t004

###### Multivariate logistic regression of moderate to high nutritional risk.
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  Variable                     Categories                        OR     95% CI        *P*
  ---------------------------- --------------------------------- ------ ------------- -------
  Stage at diagnosis           Late (III--IV) vs Early (I--II)   2.54   1.14--5.69    0.023
  ECOG performance status      2--4 vs 0--1                      3.04   1.57--5.88    0.001
  Geriatric depression scale   Depressed (\>5) vs Normal (≤5)    5.99   1.99--18.02   0.001
  Haemoglobin, g/dL            Abnormal (\<12) vs Normal (≥12)   3.00   1.54--5.84    0.001

Abbreviation: OR, odds ratio; CI, confidence interval; ECOG, Eastern Cooperative Oncology Group

Clinical scoring system {#sec015}
-----------------------

A nomogram was constructed based on the multivariate model as shown in [Fig 1](#pone.0156008.g001){ref-type="fig"}. The model achieved both calibration (Hosmer-Lemeshow test's p = 0.172) and discrimination (AUC = 0.799). Based on bootstrapping, the bias-corrected AUC of the multivariate model was slightly lower at 0.788, indicating that the model retained a good discrimination. The predicted probabilities of moderate to high nutritional risk based on the model approximated the actual outcomes well ([Fig 2](#pone.0156008.g002){ref-type="fig"}).

![Nomogram for moderate to high nutritional risk in an elderly Asian cancer patient.\
The predicted probability of moderate to high nutritional risk of a patient is obtained by first locating the patient's stage at diagnosis, Eastern Cooperative Oncology Group \[ECOG\] performance status, geriatric depression scale and haemoglobin on each axis. Draw a vertical line to the "points" axis to determine the number of points to assign for each variable's value. Sum all the points for all variables, locate the total sum on the "Total Points," and draw a straight line down to locate the probability of moderate to high nutritional risk corresponding to the sum.](pone.0156008.g001){#pone.0156008.g001}

![Calibration plot of the final model for moderate to high nutritional risk.](pone.0156008.g002){#pone.0156008.g002}

Discussion {#sec016}
==========

We have previously reported nutritional risk as assessed using the NSI to be predictive of survival in elderly Asian patients with cancer\[[@pone.0156008.ref024]\]. We have shown here a high prevalence (73.9%) of nutritional risk in our cohort of elderly Asian cancer patients. To our knowledge, our study is the first to investigate the relationship between nutritional risk, defined by the NSI and all domains of the CGA in addition to readily available clinical parameters specifically in a cohort of elderly Asian patients with cancer. We have identified four factors; presence of depression, advanced stage, poor performance status, and anaemia as significantly associated on multivariate analysis with moderate to high nutritional risk.

In a recent cohort study (The ELCAPA-05), the Mini Nutritional Assessment (MNA) was used as the primary evaluation criterion\[[@pone.0156008.ref007]\]. This tool requires a professional to complete and evaluates risk of undernutrition through measures of anthropometry, dietary and clinical global assessment in addition to self-perception of health and nutritional status\[[@pone.0156008.ref034]\]. A total of 643 patients were included in the survey\[[@pone.0156008.ref007]\]. Similar to our study, the authors highlighted a high prevalence of malnutrition of 20.7% and 43.5% at risk of malnutrition in their cohort of elderly French cancer patients\[[@pone.0156008.ref007]\]. The presence of geriatric syndromes such as cognitive impairment, depressed mood and fall risk were independent risk factors for malnutrition\[[@pone.0156008.ref007]\]. In particular, depressed mood was associated with a 1.5--3 times risk for malnutrition in their cohort of patients\[[@pone.0156008.ref007]\]. The relationship between nutritional status and psychological status in patients with colorectal cancers was investigated in a Canadian study not limited to elderly patients\[[@pone.0156008.ref035]\]. Depression was identified as an independent predictor of risk of malnutrition when controlling for age, gender, marital status and weight change\[[@pone.0156008.ref035]\]. Further work is required to investigate the causal relationship between depression and malnutrition.

Advanced tumor stage, a consequence of disease progression is a well-established poor prognostic factor\[[@pone.0156008.ref014],[@pone.0156008.ref024]\]. Nutritional risk likely reflects the consequence of having advanced disease and the general health of patients. In a large study of 14972 Korean cancer patients, the proportion of patients with high risk for malnutrition as defined by BMI, serum albumin, total lymphocyte count and dietary intake, increased with cancer stage\[[@pone.0156008.ref036]\]. Similarly, in the SCReening the Nutritional status in Oncology (SCRINIO) study of 1000 oncology outpatients in Italy, weight loss was higher in patients with more advanced stage of disease and compromised performance status\[[@pone.0156008.ref037]\].

Nutritional risk as defined by the Nutritional Risk Score (NRS) was noted to be higher in patients with poorer performance status\[[@pone.0156008.ref037]\]. Similarly, a multicenter observational study conducted in France identified a WHO performance status score of 2 or more as a risk factor for malnutrition as defined by 2 anthropometric indicators, the level of weight loss and BMI\[[@pone.0156008.ref015]\]. Performance status is a commonly cited factor independently associated with mortality\[[@pone.0156008.ref038]\].

Anaemia, a common finding in patients with cancer may adversely influence the management of elderly cancer patients by limiting dose intensity of treatment and hence affecting efficacy. In a prospective survey, Mancuso et al analyzed the correlation between CGA parameters and anemia\[[@pone.0156008.ref039]\]. Functional decline, cognitive decline, depression and poor quality of life were identified as associated with low haemoglobin levels\[[@pone.0156008.ref039]\]. In a review of the literature of elderly cancer patients, anaemia has not yet been found to be a predictor for risk of malnutrition. Hence this is the first study to report this association.

Early identification of malnutrition allows for timely referral to appropriately trained health care professionals leading to interventions that may modify risk factors and potentially improve outcomes. We report here an exploratory analysis identifying four factors that should be further explored for subsequent use in clinical trials and therapeutic recommendations. We have incorporated these four factors in developing a clinical scoring system to predict an individual elderly patient's risk for malnutrition. As far as we are aware, this is the first scoring system utilizing clinical factors and parameters providing an individualised malnutrition risk assessment in this unique population of patients.

There are however some limitations to our study. The NSI checklist was originally applied in a cohort of non-instituitionalised, white, older persons without a specific diagnosis of cancer\[[@pone.0156008.ref020]\]. Few studies have validated the NSI checklist and data for its predictive value with regards to mortality remains weak\[[@pone.0156008.ref018],[@pone.0156008.ref040]--[@pone.0156008.ref042]\]. Our study population is small and heterogeneous in terms of the tumor types. The patients included in our analysis are outpatients representing a group of fitter patients. The majority of our patients had GI tract cancers with an underrepresentation of other solid tumour types. This reflects selection bias in the conduct of this study the results of which may therefore not be completely extrapolated to the general elderly cancer patient population. GI tract cancer patients may have higher risk of malnutrition due to the site and nature of their disease compared to those with other tumor types. Given several reports on varying prevalence of malnutrition based on primary tumour sites\[[@pone.0156008.ref036]\], future studies should be conducted focusing on specific tumor types.

In taking the findings of this study to the next step, we plan to prospectively validate this score in a separate population of elderly Asian cancer patients.

In conclusion, a significant number of elderly Asian cancer patients are at nutritional risk. Physicians need to have a strong index of suspicion of under nutrition in the elderly population. Advanced stage of cancer, poor performance status, depression and anaemia are independent predictors of moderate to high nutritional risk.
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